Showing results (11-20 of 206) with videos related to
Sort By:
Pageof 21
Expert Opinion on Drug Safety|March 8, 2008
The safety of dopamine agonists in the treatment of Parkinson's diseaseUbaldo Bonuccelli, Roberto CeravoloRivista Di Psichiatria|June 11, 2013
[Psychopathological spectrum in behavioral variant frontotemporal dementia]Michele Poletti, Ubaldo BonuccelliClinical Pharmacokinetics|July 8, 2003
Clinical pharmacokinetics of cabergolinePaolo Del Dotto, Ubaldo BonuccelliNeurology|October 13, 2006
New pharmacologic horizons in the treatment of Parkinson diseaseUbaldo Bonuccelli, Paolo Del DottoJournal of Clinical and Experimental Neuropsychology|December 9, 2010
Iowa gambling task in Parkinson's diseaseMichele Poletti, Paolo Cavedini, Ubaldo BonuccelliExpert Review of Neurotherapeutics|June 4, 2015
Apomorphine hydrochloride for the treatment of Parkinson's diseaseElisa Unti, Roberto Ceravolo, Ubaldo BonuccelliExpert Opinion on Pharmacotherapy|September 14, 2018
Advances in the pharmacotherapeutic management of dementia with Lewy bodiesGiovanni Palermo, Roberto Ceravolo, Ubaldo BonuccelliJournal of Neurology|April 23, 2011
The neuropsychological correlates of pathological lying: evidence from behavioral variant frontotemporal dementiaMichele Poletti, Paolo Borelli, Ubaldo BonuccelliParkinsonism & Related Disorders|April 15, 2011
Mild cognitive impairment and cognitive reserve in Parkinson's diseaseMichele Poletti, Murat Emre, Ubaldo BonuccelliParkinsonism & Related Disorders|February 4, 2010
Role of dopamine receptor agonists in the treatment of early Parkinson's diseaseUbaldo Bonuccelli, Paolo Del Dotto, Olivier RascolPageof 21